← Leaderboards
Li Tang
Roswell Park Cancer Institute Corp
$8,006,573
Attributed
$16,506,200
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,506,200 · 8
By mechanism
R01$12,689,304 · 4
U01$2,593,082 · 1
K07$661,991 · 1
R21$440,154 · 1
R03$121,669 · 1
Top collaborators
- Marilyn L Kwan13 shared
- Lawrence H Kushi6 shared
- Karen Hye-Cheon Kim Yeary2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsHigh RiskDiagnosisRecurrenceCancer RecurrenceCancer PatientPreventLife StyleCancer SurvivorGeneticMuscleTumor ProgressionTumorIntravesicalLifestyle FactorsMalignant Neoplasm Of Urinary BladderDietClinical CareGenesProspective StudiesAdverse EffectsSmokingNewly DiagnosedCancer Prognosis
Grant awards (23)
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication$2,683,351
R01 · FY2025 · CA · contact PI
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer$874,216
U01 · FY2025 · CA
A scalable cruciferous vegetable intervention to reduce bladder cancer recurrence and progression$717,150
R01 · FY2025 · CA
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication$1,256,124
R01 · FY2024 · CA · contact PI
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer$837,461
U01 · FY2024 · CA
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication$1,289,789
R01 · FY2023 · CA · contact PI
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer$881,405
U01 · FY2023 · CA
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication$1,318,389
R01 · FY2022 · CA · contact PI
Flaxseed effects on gut microbial metabolism and circulating inflammation-related metabolic profiles in African American and non-Hispanic white women$398,590
R01 · FY2021 · AT · contact PI
A pragmatic dietary intervention to improve bladder cancer survivorship$440,154
R21 · FY2020 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$926,417
R01 · FY2018 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$99,577
R01 · FY2018 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$982,302
R01 · FY2017 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$986,987
R01 · FY2016 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$990,772
R01 · FY2015 · CA
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis$132,486
K07 · FY2015 · CA · contact PI
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$1,039,856
R01 · FY2014 · CA
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis$132,486
K07 · FY2014 · CA · contact PI
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis$132,486
K07 · FY2013 · CA · contact PI
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis$132,261
K07 · FY2012 · CA · contact PI
Racial disparities in human endogenous retrovirus and breast cancer$44,721
R03 · FY2012 · CA · contact PI
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis$132,272
K07 · FY2011 · CA · contact PI
Racial disparities in human endogenous retrovirus and breast cancer$76,948
R03 · FY2011 · CA · contact PI